Skip to main content
. 2022 Mar 30;19(3):146–156. doi: 10.1007/s11897-022-00542-5

Fig. 1.

Fig. 1

Evaluation and management of HF defined by ACC/AHA guidelines: evolution and recommended therapy by HF stage. Adapted from Hunt [50]. ACEI, angiotensin-converting enzyme inhibitors; ARB, angiotensin receptor blockers; EF, ejection fraction; FHx CM, family history of cardiomyopathy; HF, heart failure; LV, left ventricular LVH, left ventricular hypertrophy; MI, myocardial infarction